Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma

Journal of the National Cancer Institute

Volumn 103, Issue 16, 2011, Pages 1227-1235

  Chatzinasiou, Foteini ^a   Lill, Christina M ^b,c   Kypreou, Katerina ^a   Stefanaki, Irene ^a   Nicolaou, Vasiliki ^a   Spyrou, George ^d   Evangelou, Evangelos ^e   Roehr, Johannes T ^b,f   Kodela, Elizabeth ^a   Katsambas, Andreas ^a   Tsao, Hensin ^g   Ioannidis, John P A ^e,h,i,j   Bertram, Lars ^b   Stratigos, Alexander J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^e UNIVERSITY OF IOANNINA   (Greece)

^f FREIE UNIVERSITÄT BERLIN   (Germany)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Department of Medicine   (United States)

^j TUFTS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASIP GENE; CDKN2A GENE; CHROMOSOME 11Q; CHROMOSOME 16Q; CHROMOSOME 20Q; CHROMOSOME 5P; CHROMOSOME 9P; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN; MC1R GENE; MELANOMA; MTAP GENE; MYH7B GENE; ONCOGENE; PIGU GENE; PRIORITY JOURNAL; REVIEW; SLC45A2 GENE; SYSTEMATIC REVIEW; TYR GENE; TYRP1 GENE;

AGOUTI SIGNALING PROTEIN; ANTIGENS, NEOPLASM; CARDIAC MYOSINS; CONFOUNDING FACTORS (EPIDEMIOLOGY); CYCLIN-DEPENDENT KINASE INHIBITOR P16; DATABASES, GENETIC; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MELANOMA; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; META-ANALYSIS AS TOPIC; MOLECULAR EPIDEMIOLOGY; MYOSIN HEAVY CHAINS; NEOPLASM PROTEINS; OXIDOREDUCTASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTORS, CALCITRIOL; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SKIN NEOPLASMS;

EID: 80051959840     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr219     Document Type: Review

References (67)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
2. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol. 2009;20(suppl 6):vi1-vi7.
3. Tucker MA, Goldstein AM. Melanoma etiology: where are we? Oncogene. 2003;22(20):3042-3052. (Pubitemid 36713754)
4. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14):2040-2059. (Pubitemid 41337946)
5. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005; 41(1):28-44. (Pubitemid 40029657)
6. Risch N. Genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomark Prev. 2001;10(7):733-741. (Pubitemid 32695152)
7. Shekar SN, Duffy DL, Youl P, et al. A population-based study of Australian twins with melanoma suggests a strong genetic contribution to liability. J Invest Dermatol. 2009;129(9):2211-2219.
8. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nat Genet. 1994;8(1):15-21. (Pubitemid 24274055)
9. Goldstein AM, Chan M, Harland M, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet. 2007;44(2):99-106.
10. Meyle KD, Guldberg P. Genetic risk factors for melanoma. Hum Genet. 2009;126(4):499-510.
11. Lin J, Hocker TL, Singh M, Tsao H. Genetics of melanoma predisposition. Br J Dermatol. 2008;159(2):286-291. (Pubitemid 352009867)
12. Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol. 2001;117(2):294-300. (Pubitemid 34205714)
13. Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet. 2000;66(1):176-186. (Pubitemid 30481481)
14. Fargnoli MC, Argenziano G, Zalaudek I, Peris K. High- and low-penetrance cutaneous melanoma susceptibility genes. Expert Rev Anticancer Ther. 2006; 6(5):657-670. (Pubitemid 44192883)
15. Bishop DT, Demenais F, Iles MM, et al. Genome-wide association study identifes three loci associated with melanoma risk. Nat Genet. 2009; 41(8):920-925.
16. Brown KM, Macgregor S, Montgomery GW, et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet. 2008; 40(7):838-840. (Pubitemid 351913651)
17. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39(1):17-23. (Pubitemid 46026496)
18. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40(7):827-834. (Pubitemid 351913655)
19. Lill CM, Roehr JT, McQueen MB, et al. The PDGene Database. Alzheimer Research Forum. http://www.pdgene.org/. Accessed July 31, 2010.
20. Castaldi PJ, Cho MH, Cohn M, et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet. 2010;19(3):526-534.
21. Vineis P, Manuguerra M, Kavvoura FK, et al. A field synopsis on low-penetrance variants in DNA repairs genes and cancer susceptibility. J Natl Cancer Inst. 2009;101(1):24-36.
22. Dolan SM, Hollegaard MV, Merialdi M, et al. Synopsis of preterm birth genetic association studies: the preterm birth genetics knowledge base (PTBGene). Public Health Genomics. 2010;13(7-8):514-523.
23. Chatzinasiou F, Lill CM, Kypreou K, et al. The MelGene database. htt p://www.melgene.org/. Accessed May 3, 2011.
24. PubMed: U.S. National Library of Medicine National Institutes of Health. http://www.ncbi.nlm.nih.gov/pubmed.
25. Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ. A navigator for human genome epidemiology. Nat Genet. 2008;40(2):124-125.
26. MMMP: Melanoma Molecular Map Project. http://www.mmmp.org/ MMMP. Accessed October 14, 2010.
27. Nan H, Kraft P, Hunter DJ, Han J. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int J Cancer. 2009;125(4):909-917.
28. Gudbjartsson DF, Sulem P, Stacey SN, et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet. 2008;40(7):886-891. (Pubitemid 351913649)
29. Falchi M, Bataille V, Hayward NK, et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet. 2009;41(8):915-919.
30. Stacey SN, Sulem P, Masson G, et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet. 2009;41(8):909-914.
31. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41(2): 221-227.
32. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. (Pubitemid 17189972)
33. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. (Pubitemid 34746062)
34. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560. (Pubitemid 37088507)
35. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007;335(7626):914-916. (Pubitemid 350076978)
36. Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37(1): 120-132. (Pubitemid 351228620)
37. Khoury MJ, Bertram L, Boffetta P, et al. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol. 2009;170(3): 269-279.
38. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443-3457. (Pubitemid 44575162)
39. Ioannidis JP, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4(3):245-253. (Pubitemid 47400532)
40. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996-1006; URL:http://genome.ucsc.edu. (Pubitemid 34662293)
41. The International HapMap Consortium. The International HapMap Project. Nature. 2003;426(6968):789-796.
42. Yeh I, Bastian BC. Genome-wide associations studies for melanoma and nevi. Pigment Cell Melanoma Res. 2009;22(5):527-528.
43. Gerstenblith MR, Shi J, Landi MT. Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis. Pigment Cell Melanoma Res. 2010;23(5):587-606.
44. Mocellin S, Nitti D. Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer. 2008;113(9):2398-2407.
45. Randerson-Moor JA, Taylor JC, Elliott F, et al. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer. 2009;45(18):3271-3281.
46. Gandini S, Raimondi S, Gnagnarella P, Doré JF, Maisonneuve P, Testori A. Vitamin D and skin cancer: a meta-analysis. Eur J Cancer. 2009;45(4): 634-641.
47. Raimondi S, Sera F, Gandini S, et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer. 2008;122(12):2753-2760. (Pubitemid 351631377)
48. Mocellin S, Verdi D, Nitti D. DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis. Carcinogenesis. 2009;30(10):1735-1743.
49. Duffy DL, Zhao ZZ, Sturm RA, Hayward NK, Martin NG, Montgomery GW. Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J Invest Dermatol. 2010;130(2):520-528.
50. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2005;24(9): 1291-1306. (Pubitemid 40585169)
51. Landi MT, Kanetsky PA, Tsang S, et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst. 2005;97(13):998-1007. (Pubitemid 41430565)
52. Debniak T, Gapska P, Serrano-Fernandez P, et al. Modest association of malignant melanoma with the rs910873 and rs1885120 markers on chromosome 20: a population-based study. Melanoma Res. 2010;20(2): 159-160.
53. Siontis KC, Patsopoulos NA, Ioannidis JP. Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. Eur J Hum Genet. 2010;18(7):832-837.
54. Ioannidis JP, Castaldi P, Evangelou E. A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. J Natl Cancer Inst. 2010;102(12):846-858.
55. 1000 Genomes Project Consortium, Durbin RM, Abecasis GR, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061-1073.
56. Ashley EA, Butte AJ, Wheeler MT, et al. Clinical assessment incorporating a personal genome. Lancet. 2010;375(9725):1525-1535.
57. Beaumont KA, Shekar SN, Newton RA, et al. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet. 2007;16(18):2249-2260. (Pubitemid 47354907)
58. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet. 1995;11(3):328-330.
59. Flanagan N, Healy E, Ray A, et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet. 2000;9(17):2531-2537.
60. Tripathi RK, Strunk KM, Giebel LB, Weleber RG, Spritz RA. A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity. Gene Expr. 1991;1(2):103-110.
61. Sulem P, Gudbjartsson DF, Stacey SN, et al. Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet. 2008; 40(7):835-837. (Pubitemid 351913648)
62. Sturm RA, Teasdale RD, Box NF. Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene. 2001; 277(1-2):49-62. (Pubitemid 32972108)
63. *0201-restricted T cells. Cancer Res. 2001;61(3): 1089-1094. (Pubitemid 32174429)
64. Graf J, Hodgson R, van Daal A. Single nucleotide polymorphisms in the MATP gene are associated with normal human pigmentation variation. Hum Mutat. 2005;25:278-284. (Pubitemid 40365146)
65. Fernandez LP, Milne RL, Pita G, et al. SLC45A2: a novel malignant melanoma-associated gene. Hum Mutat. 2008;29(9):1161-1167.
66. Guedj M, Bourillon A, Combadières C, et al. Variants of the MATP/ SLC45A2 gene are protective for melanoma in the French population. Hum Mutat. 2008;29(9):1154-1160.
67. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95(11):806-812. (Pubitemid 36798427)